AI summary · may contain errors
Epigenomic and three-dimensional chromatin remodeling in trastuzumab-resistant HER2+ breast cancer cells is linked to transcriptional reprogramming, with SGK1 showing increased promoter H3K4me3 and stronger chromatin interactions.
- Open access
